We are live on ! Find out more
Bessemer Group

Bessemer Group Portfolio holdings

AUM $63.6B
1-Year Est. Return 28.76%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$49.9B
AUM Growth
+$3.01B
Cap. Flow
-$1.03B
Cap. Flow %
-2.07%
Top 10 Hldgs %
30.34%
Holding
2,029
New
380
Increased
736
Reduced
324
Closed
168

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$274M
2
INTU icon
Intuit
INTU
+$187M
3
MSFT icon
Microsoft
MSFT
+$141M
4
NOC icon
Northrop Grumman
NOC
+$135M
5
ADBE icon
Adobe
ADBE
+$133M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$349M
2
BX icon
Blackstone
BX
+$204M
3
CMCSA icon
Comcast
CMCSA
+$177M
4
BMY icon
Bristol-Myers Squibb
BMY
+$168M
5
V icon
Visa
V
+$149M

Sector Composition

Rank Sector Weight
1 Technology 23.71%
2 Consumer Discretionary 12.92%
3 Financials 12.8%
4 Healthcare 12.72%
5 Communication Services 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRG icon
1751
Kite Realty
KRG
$5.91B
$2K ﹤0.01%
100
-209
-68% -$4.47K
MAC icon
1752
Macerich
MAC
$7.52B
$2K ﹤0.01%
+100
New +$1.87K
NDSN icon
1753
Nordson
NDSN
$16.9B
$2K ﹤0.01%
6
-166
-97% -$42.5K
NNDM
1754
Nano Dimension
NNDM
$314M
$2K ﹤0.01%
500
NSIT icon
1755
Insight Enterprises
NSIT
$3.77B
$2K ﹤0.01%
20
-77
-79% -$7.66K
OLLI icon
1756
Ollie's Bargain Outlet
OLLI
$4.17B
$2K ﹤0.01%
+48
New +$2.92K
OSPN icon
1757
OneSpan
OSPN
$572M
$2K ﹤0.01%
+120
New +$2.24K
PHAT icon
1758
Phathom Pharmaceuticals
PHAT
$930M
$2K ﹤0.01%
101
PROF
1759
Profound Medical
PROF
$263M
$2K ﹤0.01%
165
QEFA icon
1760
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.05B
$2K ﹤0.01%
20
RIGL icon
1761
Rigel Pharmaceuticals
RIGL
$712M
$2K ﹤0.01%
73
SLP icon
1762
Simulations Plus
SLP
$371M
$2K ﹤0.01%
43
URBN icon
1763
Urban Outfitters
URBN
$6.44B
$2K ﹤0.01%
+70
New +$2.22K
WINA icon
1764
Winmark
WINA
$1.24B
$2K ﹤0.01%
7
XHE icon
1765
State Street SPDR S&P Health Care Equipment ETF
XHE
$161M
$2K ﹤0.01%
+21
New +$2.54K
QVCGA
1766
DELISTED
QVC Group Inc Series A
QVCGA
$2K ﹤0.01%
6
ACCD
1767
DELISTED
Accolade Inc
ACCD
$2K ﹤0.01%
83
CSII
1768
DELISTED
Cardiovascular Systems, Inc.
CSII
$2K ﹤0.01%
+111
New +$2.96K
SNP
1769
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$2K ﹤0.01%
45
ENDP
1770
DELISTED
Endo International plc
ENDP
$2K ﹤0.01%
+545
New +$2.64K
NP
1771
DELISTED
Neenah, Inc. Common Stock
NP
$2K ﹤0.01%
+48
New +$2.35K
EPAY
1772
DELISTED
Bottomline Technologies Inc
EPAY
$2K ﹤0.01%
+40
New +$1.87K
KRA
1773
DELISTED
Kraton Corporation
KRA
$2K ﹤0.01%
+50
New +$2.29K
GRUB
1774
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$2K ﹤0.01%
206
-1,252
-86% -$16.7K
TTP
1775
DELISTED
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
$2K ﹤0.01%
+86
New +$2.1K

Similar funds

Bessemer Group's Q4 2021 Portfolio in Review

As of Q4 2021, Bessemer Group held 2,029 positions worth $49.9B, up 6.4% from $46.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bessemer Group's Q4 2021 filing shows 380 new, 736 increased, 324 reduced and 168 closed positions. Its largest new stake was Nu Holdings: 1,208,052 shares worth $11.3M. The largest sale was PayPal, an estimated $349M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Bessemer Group's largest Q4 2021 buy was Nu Holdings: 1,208,052 shares worth $11.3M.
  • Bessemer Group added most to NVIDIA in Q4 2021, an estimated $274M increase.
  • Bessemer Group's biggest Q4 2021 reduction was PayPal, cutting an estimated $349M.
  • Bessemer Group fully exited Invesco Preferred ETF in Q4 2021, selling an estimated $132M.
  • Bessemer Group's ten largest holdings make up 30% of its $49.9B portfolio in Q4 2021.
  • Bessemer Group opened 380 new positions and closed 168 in Q4 2021.
  • Bessemer Group's portfolio value rose 6.4% quarter-over-quarter to $49.9B.

Based on Bessemer Group's 13F filing for Q4 2021, filed 27 Jan 2022.